A previous randomized clinical trial (RCT) from the United States reported that the use of CGM (N = 105) compared with usual care (N = 53) resulted in a greater decrease in HbA1c levels over the course of 24 weeks in T1DM patients who required multiple daily insulin injections (5). Here, INS is linked to type 1 diabetes mellitus.